Janus Henderson Group
MNTA

Janus Henderson Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Janus Henderson Group’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,488,914
Closed -$49.5M – 1396
2020
Q2 		$49.5M Buy
1,488,914
+1,472,872
+9,181% +$46.9M 0.03% 493
2020
Q1 		$436K Buy
+16,042
New +$447K ﹤0.01% 1192
2018
Q4 		– Sell
-1,642,494
Closed -$43.2M – 1456
2018
Q3 		$43.2M Sell
1,642,494
-566,492
-26% -$15.3M 0.02% 631
2018
Q2 		$45.2M Buy
2,208,986
+336,859
+18% +$7.23M 0.03% 581
2018
Q1 		$34M Buy
+1,872,127
New +$31.2M 0.02% 650

Other funds holding MNTA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.02B AUM 126.33% 1-Year Est. Return